AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Original Transcript:\n39+6, P0\n1st episode reduced fetal movements - ongoing slight reduction since earlier today\nno bleeding\nno abnormal vaginal discharge\nno PET symptoms\nno pain\nhaving irregular tightenings - not painful\n\nBG:\nMacrosomic baby on USS in 3rd trimester, normal fluid, hasn't been counselled re macrosomia\n\nObs: N\nUrine: N\nCTG: Stable FHR, didn't meet Dawes-Redman criteria after 1 hour, STV 5, didn't meet due to \n\"No episodes of high variation \"\n\"long term variation during episodes of high variation below acceptable level\"\n\nOE: cephalic, 2/5 PA, no palpable tightenings\n\nUSS: cephalic\n\nDiscussion:\nDFM at term: associated weakly with adverse outcomes like stillbirth, advised AFFIRM trial didn't show any clear benefit of IOL for this reason\nCTG not meeting DR criteria: given tightenings are both non-painful and not palpable, DR applies, therefore consider this additional risk factor, would advise admit and repeat CTG within 4 hour (as per protocol) at a minimum\nMacrosomia: good evidence (and stands to reason) risk of shoulder dystocia proportional to fetal size, delivery earlier reduces this\n\nOptions:\nExpectant / sweep / IOL / CS\nDiscussed each including process, risks, benefits\n\nAdvice:\nI advised admission and repeat CTG - patient keen on going home to eat and come back for this - agreed\nI advised either sweep or IOL to reduce the small additional risks of prolonged pregnancy - patient not keen\n\nCombined Guideline Analyses:\n\n\n=== GUIDELINE 1: CG1116 Fetal Heart Monitoring & Sampling ===\nSince the guideline content for \"CG1116 Fetal Heart Monitoring & Sampling\" is not available, I cannot provide specific recommendations referencing this guideline. However, based on general obstetric guidelines and standard practice, here are some potential recommendations for improving the clinical note:\n\n### Very Important Recommendations\n1. [Additional information needed] - Document whether the patient received counseling about macrosomia risks (shoulder dystocia, birth injury, etc.) and whether this was documented in the notes.\n   Reason: Macrosomia is a significant risk factor for adverse outcomes, and proper counseling is essential for informed decision-making (standard obstetric practice).\n\n2. [Different management plan] - Consider more urgent fetal assessment (e.g., immediate repeat CTG or ultrasound for biophysical profile) given reduced fetal movements + non-reassuring CTG (did not meet Dawes-Redman criteria).\n   Reason: Reduced fetal movements + non-reassuring CTG may indicate fetal compromise, warranting closer monitoring (standard obstetric practice for fetal surveillance).\n\n### Somewhat Important Recommendations\n1. [Improved patient advice] - Provide clearer documentation of the risks/benefits of expectant management vs. induction of labor (e.g., specific stillbirth risk statistics, shoulder dystocia risk with macrosomia).\n   Reason: Better patient counseling improves informed decision-making (standard for shared decision-making in obstetrics).\n\n2. [Additional information needed] - Document whether a growth scan was recently repeated to confirm ongoing macrosomia and amniotic fluid volume.\n   Reason: Macrosomia and fluid status may change near term, affecting management decisions (standard obstetric practice).\n\n### Less Important Recommendations\n1. [Additional information needed] - Include more details on the CTG trace (e.g., baseline rate, decelerations, accelerations) rather than just STV and variation comments.\n   Reason: More complete CTG documentation improves interpretation and future review (standard for CTG documentation).\n\n2. [Improved patient advice] - Document whether the patient was given written information on reduced fetal movements and macrosomia risks.\n   Reason: Improves patient understanding and medico-legal documentation (general best practice).\n\n### Unimportant Recommendations\n1. [Additional information needed] - Consider documenting the patient's specific reasons for declining sweep/IOL (e.g., personal preferences, cultural factors).\n   Reason: Minor point, but can help tailor future counseling (general communication best practice).\n\nWithout access to the specific guideline (CG1116), these recommendations are based on general obstetric principles. If you can provide the guideline content, I can refine these to better match its specific recommendations.\n\n=== GUIDELINE 2: CG1192 Large for Gestational Age ===\n### Very Important Recommendations  \n**Additional information needed** - Document whether a Glucose Tolerance Test (GTT) was offered or performed, given the macrosomic baby and lack of documented diabetes screening.  \n**Reason**: The guideline (CG1192, Section 7.0) recommends offering a GTT if the fetal abdominal circumference (AC) is >95th centile, especially in cases of suspected macrosomia, to rule out gestational diabetes as a contributing factor.  \n\n**Improved patient advice** - Provide clearer statistics on shoulder dystocia risks based on estimated fetal weight (EFW) ranges (e.g., 5% at 4–4.25 kg, 9% at 4.25–4.5 kg, etc.).  \n**Reason**: The guideline (Section 9.0) emphasizes discussing specific risks at different weight thresholds to support informed decision-making. The note mentions macrosomia but lacks detailed risk stratification.  \n\n**Different management plan** - Explicitly document a consultant-led discussion regarding the option of cesarean section (CS) for EFW ≥4.5 kg, as per the guideline threshold.  \n**Reason**: The guideline (Section 10.0) states CS should be considered for EFW ≥4.5 kg, requiring consultant involvement. The note does not confirm this discussion occurred.  \n\n---\n\n### Somewhat Important Recommendations  \n**Improved patient advice** - Include a discussion about the 10–20% error rate in ultrasound weight estimation and its implications for birth planning.  \n**Reason**: The guideline (Section 6.0) highlights the importance of addressing scanning inaccuracies to manage patient expectations.  \n\n**Additional information needed** - Document whether polyhydramnios was assessed, given the macrosomia and reduced fetal movements.  \n**Reason**: The guideline (Section 9.1) recommends evaluating polyhydramnios in LGA cases, as it may indicate underlying conditions (e.g., diabetes or TOF).  \n\n---\n\n### Less Important Recommendations  \n**Improved patient advice** - Reiterate the option of expectant management with repeat growth scans if IOL is declined, as per the guideline’s 2-week follow-up recommendation.  \n**Reason**: The guideline (Section 9.0) advises repeat scans for ongoing assessment if IOL is deferred, but this is secondary to immediate risks.  \n\n**Additional information needed** - Clarify if the patient was counseled about the increased risk of 3rd/4th-degree tears with IOL.  \n**Reason**: The guideline (Section 11.0) notes this risk, but it is less critical than shoulder dystocia discussions.  \n\n---\n\n### Unimportant Recommendations  \n**Improved patient advice** - Mention the potential for postpartum disappointment if the baby’s actual weight differs significantly from estimates.  \n**Reason**: The guideline (Section 12.0) suggests this discussion, but it is minor compared to acute clinical risks.  \n\n**Formatting** - Standardize the documentation of CTG findings (e.g., \"STV 5\" vs. \"stable FHR\") for clarity.  \n**Reason**: This is a minor improvement for consistency but does not impact guideline adherence.  \n\n---\n\n### Summary  \nThe note aligns well with the guideline’s emphasis on shared decision-making but lacks documentation of diabetes screening, detailed risk quantification, and consultant input for CS. Addressing these gaps would enhance compliance and patient safety.\n\n=== GUIDELINE 3: CG13019 Triage of Maternity Patients Guideline ===\nSince the guideline content (CG13019 Triage of Maternity Patients Guideline) is not provided, I cannot make specific recommendations referencing the guideline. However, based on standard obstetric practice and common guidelines for reduced fetal movements (DFM) and macrosomia, here are general recommendations:\n\n### Very Important Recommendations\n[Additional information needed] - Document whether the patient received formal counseling about macrosomia risks (shoulder dystocia, birth injury, etc.) and whether an estimated fetal weight was discussed.  \nReason: Macrosomia counseling is critical for informed decision-making regarding delivery timing/mode.  \n\n[Different management plan] - Given DFM + macrosomia + non-reassuring CTG (not meeting Dawes-Redman), stronger recommendation for admission/IOL should be documented, including clear rationale if deferring.  \nReason: DFM + borderline CTG increases risk; macrosomia compounds this. AFFIRM trial applies to isolated DFM, not high-risk cases.  \n\n### Somewhat Important Recommendations  \n[Improved patient advice] - Document specific risks of macrosomia (e.g., \"2-10% shoulder dystocia risk if EFW >4.5kg\") and risks/benefits of early delivery vs. expectant management.  \nReason: Quantifiable risks improve shared decision-making.  \n\n[Additional information needed] - Document if a growth scan was offered/repeated to confirm macrosomia and assess fluid volume.  \nReason: Serial growth assessment is often recommended for suspected macrosomia.  \n\n### Less Important Recommendations  \n[Improved patient advice] - Include written materials about DFM/macrosomia given patient declined immediate intervention.  \nReason: Enhances safety for expectant management.  \n\n### Unimportant Recommendations  \n[Additional information needed] - Consider documenting maternal glucose status (e.g., GDM screening results).  \nReason: Macrosomia may be associated with undiagnosed GDM, though not urgent in this context.  \n\nNote: Without the specific guideline, these are general recommendations. The \"very important\" items address critical safety gaps (macrosomia counseling and DFM+macrosomia risk stratification). The CTG interpretation (Dawes-Redman) and AFFIRM trial applicability are particularly context-dependent—the guideline would ideally clarify local protocols for borderline CTGs in high-risk pregnancies.\n\n=== GUIDELINE 4: FIGO Consensus Guidelines on Intrapartum Fetal Monitoring: Cardiotocography ===\n### Very Important Recommendations  \n**Additional information needed** - Document whether the patient was counseled about macrosomia risks (shoulder dystocia, birth injury) and whether this counseling included discussion of elective cesarean section as an option.  \nReason: The note states the patient \"hasn't been counselled re macrosomia,\" which is critical given the increased risks associated with fetal macrosomia (guideline emphasizes integrating clinical context with CTG findings).  \n\n**Different management plan** - Stronger recommendation for admission and continuous CTG monitoring given the combination of reduced fetal movements (RFM) + non-reassuring CTG (failure to meet Dawes-Redman criteria) + macrosomia.  \nReason: FIGO guidelines recommend continuous CTG for high-risk situations (Section 2), and this case has multiple risk factors (RFM, borderline CTG, macrosomia). The current plan (discharge with repeat CTG in 4 hours) may delay intervention if fetal compromise develops.  \n\n---  \n\n### Somewhat Important Recommendations  \n**Improved patient advice** - Explicitly document the quantified risks of adverse outcomes with expectant management (e.g., \"The risk of stillbirth with RFM at term is approximately X% based on [citation], and macrosomia increases the risk of shoulder dystocia by Y%\").  \nReason: FIGO guidelines stress integrating clinical judgment with objective data (Section 4). Providing statistics aligns with shared decision-making.  \n\n**Additional information needed** - Clarify why the CTG did not meet Dawes-Redman criteria (e.g., quantify \"long-term variation during episodes of high variation below acceptable level\" with specific values).  \nReason: FIGO guidelines emphasize precise interpretation of variability (Section 4). Specific data would support the decision to repeat CTG vs. escalate care.  \n\n---  \n\n### Less Important Recommendations  \n**Improved patient advice** - Suggest alternative positions for CTG monitoring (e.g., lateral recumbent) if repeated.  \nReason: FIGO guidelines recommend avoiding supine positioning (Section 3), though this is less critical in this context.  \n\n**Additional information needed** - Document maternal heart rate during CTG to rule out signal confusion.  \nReason: FIGO notes simultaneous maternal heart rate monitoring can be useful (Section 3), though fetal macrosomia makes this less likely here.  \n\n---  \n\n### Unimportant Recommendations  \n**Improved patient advice** - Mention wireless CTG options if the patient prefers mobility.  \nReason: FIGO mentions wireless sensors (Section 3), but this is a minor logistical point.  \n\n---  \n\n### Key Omissions in Guideline Alignment:  \n1. **No clear escalation pathway** for persistent non-reassuring CTG (e.g., when to consider delivery). FIGO stresses prompt action for hypoxia (Section 4).  \n2. **No documentation of contractions** (frequency/duration) despite \"irregular tightenings.\" FIGO requires contraction assessment for CTG interpretation (Section 4).  \n\n**Suggested Additions to Note:**  \n- \"Macrosomia counseling completed: discussed risks of shoulder dystocia (X%), birth injury (Y%), and option of elective CS.\"  \n- \"Plan: Admit for continuous CTG due to RFM + borderline CTG + macrosomia. If CTG remains non-reassuring after 1 hour, recommend delivery (IOL/CS).\"  \n- \"Contractions: irregular, 1-2/10 mins, lasting <30 sec.\"  \n\n*Rationale: FIGO prioritizes integrating CTG with clinical risks (Section 4), and this case warrants a higher level of vigilance.*\n\n=== GUIDELINE 5: MP037 Fetal Heart Monitoring guideline 2023_Final ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations\n1. **Additional information needed** - Document the specific STV (Short-Term Variation) value from the CTG trace, as it is critical for assessing fetal wellbeing.  \n   Reason: The guideline states STV <3ms is abnormal and strongly linked to metabolic acidaemia (MP037, Section \"Short Term Variation (STV)\").  \n\n2. **Different management plan** - Immediate obstetric review should be sought given the CTG did not meet DR criteria due to \"No episodes of high variation\" and \"long-term variation during episodes of high variation below acceptable level.\"  \n   Reason: The guideline recommends urgent review by an Obstetric Registrar ≥ST3 if criteria are not met and STV is low (MP037, Section \"What to do when criteria is not met at 60 minutes\").  \n\n3. **Improved patient advice** - Clearly document the risks of macrosomia (e.g., shoulder dystocia) and the benefits of earlier delivery in the discussion with the patient.  \n   Reason: The guideline emphasizes holistic counseling for high-risk conditions like macrosomia (MP037, Introduction: \"Key Principles\").  \n\n### Somewhat Important Recommendations\n1. **Additional information needed** - Include maternal observations (BP, pulse, temperature) in the note to rule out sepsis or other contributors to abnormal CTG.  \n   Reason: Sepsis can cause fetal tachycardia or reduced variability (MP037, Appendix 3: \"Indications for CTG Use\").  \n\n2. **Different management plan** - Consider continuous CTG monitoring instead of intermittent repeats due to the additional risk factor of macrosomia.  \n   Reason: Macrosomia is an indication for continuous monitoring per guideline (MP037, Appendix 3: \"Fetal\" section).  \n\n3. **Improved patient advice** - Document a clear plan for timing of repeat CTG (e.g., \"within 4 hours as per protocol\") and contingency plans if the patient declines.  \n   Reason: The guideline specifies timeframes for repeat CTG based on STV values (MP037, Section \"What to do when criteria is not met at 60 minutes\").  \n\n### Less Important Recommendations\n1. **Additional information needed** - Note whether the fetal movement button was used during the CTG, as automatic movement detection is invalid for DR analysis.  \n   Reason: DR analysis requires manual fetal movement recording (MP037, Section \"Equipment\").  \n\n2. **Improved patient advice** - Provide written information on reduced fetal movements and macrosomia to reinforce verbal discussions.  \n   Reason: Enhances informed decision-making (MP037, Introduction: \"Key Principles\").  \n\n### Unimportant Recommendations\n1. **Additional information needed** - Document the specific Huntleigh monitor settings used (e.g., DR criteria selected).  \n   Reason: Ensures technical compliance but does not impact clinical management (MP037, Section \"Equipment\").  \n\n### Summary of Critical Gaps:\n- Lack of STV documentation and urgent escalation for non-reassuring CTG.  \n- Incomplete counseling on macrosomia risks.  \n- Absence of maternal observations to exclude confounding factors.  \n\nThese changes would align the note with guideline standards and improve patient safety.\n\nPlease extract and consolidate actionable suggestions from these multiple guideline analyses. Create combined suggestions when multiple guidelines recommend similar interventions, and prioritize suggestions based on clinical importance and consensus across guidelines. For each suggestion, include detailed context with relevant quoted text from the supporting guidelines.",
  "system_prompt": "You are a medical AI assistant that converts multiple clinical guideline analyses into structured, actionable suggestions. You will receive analyses from multiple guidelines and must create a comprehensive set of suggestions that prioritizes the most important recommendations while avoiding redundancy.\n\nYour task is to analyze the provided guideline analyses and extract specific, actionable suggestions that can be presented to the user for acceptance, rejection, or modification.\n\nCRITICAL CLINICAL REASONING REQUIREMENTS:\n- You must first understand the specific clinical scenario and current diagnosis from the transcript\n- Carefully assess whether each potential recommendation is APPROPRIATE and INDICATED for this specific case\n- Apply the fundamental principle: \"Will this investigation or intervention change management or improve patient care in this specific scenario?\"\n- Consider the clinical context: is this an acute emergency, established diagnosis, or uncertain diagnostic situation?\n- Distinguish between situations where additional testing is needed vs. where diagnosis is already established\n- Only recommend interventions that would genuinely improve patient care in THIS specific scenario\n\nMULTI-GUIDELINE PROCESSING PRINCIPLES:\n- Combine and consolidate similar recommendations from different guidelines\n- Prioritize recommendations that appear in multiple guidelines or are emphasized as critical\n- Avoid duplicate suggestions - if multiple guidelines suggest the same thing, create one combined suggestion referencing all relevant guidelines\n- When guidelines conflict, clearly note this and explain the rationale for your recommendation\n- Organize suggestions by clinical priority and relevance to the case\n\nGENERAL CLINICAL APPROPRIATENESS PRINCIPLES:\n- Do NOT suggest diagnostic investigations when the diagnosis is already established through adequate clinical and/or imaging findings\n- Do NOT recommend interventions that conflict with the current evidence-based management plan\n- Do NOT suggest serial monitoring of biomarkers when the clinical picture and imaging provide sufficient diagnostic certainty\n- Consider whether additional investigations would actually change the management approach\n- Evaluate the timing: is this the appropriate point in the clinical course for this intervention?\n- Apply cost-benefit analysis: does the potential benefit justify the intervention in this specific case?\n\nFor each suggestion you identify, return ONLY a valid JSON object with the following structure:\n{\n  \"combinedSuggestions\": [\n    {\n      \"id\": \"1\",\n      \"originalText\": \"text from transcript that needs changing OR description of missing element\",\n      \"suggestedText\": \"proposed replacement text\",\n      \"context\": \"detailed explanation of why this change is suggested, including relevant quoted text from the guidelines in quotation marks, and confirmation that this recommendation is appropriate for the specific clinical scenario\",\n      \"category\": \"addition|modification|deletion|formatting\",\n      \"priority\": \"high|medium|low\",\n      \"sourceGuidelines\": [\"Guideline 1 Name\", \"Guideline 2 Name\"],\n      \"consolidatedFrom\": \"explanation of how this suggestion combines recommendations from multiple guidelines, if applicable\"\n    }\n  ],\n  \"guidelinesSummary\": [\n    {\n      \"guidelineTitle\": \"Guideline Name\",\n      \"keyRecommendations\": \"summary of the most important recommendations from this guideline for this case\",\n      \"relevanceScore\": \"high|medium|low\"\n    }\n  ]\n}\n\nCRITICAL FORMATTING REQUIREMENTS:\n- Return ONLY the JSON object - no markdown code blocks, no explanatory text\n- Do not wrap the JSON in ```json or ``` blocks\n- Start your response directly with { and end with }\n- Use sequential numeric IDs starting from \"1\"\n- Ensure all JSON is properly formatted and valid\n\nImportant guidelines for consolidation:\n- If multiple guidelines recommend the same intervention, create ONE suggestion that references all relevant guidelines\n- Prioritize suggestions that are consistently recommended across multiple guidelines\n- When guidelines provide different specifics for the same general recommendation, include the most comprehensive/specific version\n- If guidelines conflict, choose the most appropriate recommendation for this specific case and explain why\n\nImportant guidelines for context field:\n- Provide detailed explanations including WHY the change is needed AND why it's appropriate for this specific case\n- Include specific quoted text from the relevant guidelines using quotation marks\n- Reference which specific guidelines support this recommendation\n- Explain the clinical rationale behind the suggestion\n- EXPLICITLY state why this recommendation is indicated in this particular clinical scenario\n- Make the context informative and educational",
  "transcript_length": 1405,
  "guidelines_count": 5,
  "guideline_titles": [
    "CG1116 Fetal Heart Monitoring & Sampling",
    "CG1192 Large for Gestational Age",
    "CG13019 Triage of Maternity Patients Guideline",
    "FIGO Consensus Guidelines on Intrapartum Fetal Monitoring: Cardiotocography",
    "MP037 Fetal Heart Monitoring guideline 2023_Final"
  ]
}

A: {
  "combinedSuggestions": [
    {
      "id": "1",
      "originalText": "Patient hasn't been counselled re macrosomia",
      "suggestedText": "Document detailed macrosomia counseling including risks of shoulder dystocia, birth injury, and options for delivery timing/mode (including cesarean section for EFW ≥4.5kg)",
      "context": "Multiple guidelines emphasize the critical need for macrosomia counseling. CG1192 states 'CS should be considered for EFW ≥4.5kg' (Section 10.0). FIGO guidelines stress 'integrating clinical context with CTG findings' and specifically mention discussing elective CS. MP037 emphasizes 'holistic counseling for high-risk conditions like macrosomia'. This is particularly important given the documented macrosomia and current lack of counseling.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["CG1192 Large for Gestational Age", "FIGO Consensus Guidelines on Intrapartum Fetal Monitoring", "MP037 Fetal Heart Monitoring guideline 2023"],
      "consolidatedFrom": "Combines recommendations from 3 guidelines all stressing the importance of macrosomia counseling, with CG1192 providing specific weight thresholds for CS consideration"
    },
    {
      "id": "2",
      "originalText": "Plan: repeat CTG within 4 hours",
      "suggestedText": "Admit for continuous CTG monitoring and obstetric review given RFM + non-reassuring CTG (failed DR criteria) + macrosomia",
      "context": "FIGO guidelines recommend 'continuous CTG for high-risk situations' (Section 2). MP037 states 'urgent review by an Obstetric Registrar ≥ST3 if criteria are not met and STV is low'. CG13019 analysis notes 'DFM + borderline CTG increases risk; macrosomia compounds this'. The current combination of risk factors warrants more intensive monitoring than intermittent CTG.",
      "category": "modification",
      "priority": "high",
      "sourceGuidelines": ["FIGO Consensus Guidelines on Intrapartum Fetal Monitoring", "MP037 Fetal Heart Monitoring guideline 2023", "CG13019 Triage of Maternity Patients Guideline"],
      "consolidatedFrom": "Combines recommendations from 3 guidelines all advocating for escalated monitoring in this high-risk scenario"
    },
    {
      "id": "3",
      "originalText": "No documentation of diabetes screening",
      "suggestedText": "Document whether GTT was performed/offered given macrosomia",
      "context": "CG1192 specifically recommends 'offering a GTT if fetal AC >95th centile' (Section 7.0). While not immediately urgent, this is an important gap given the known association between macrosomia and gestational diabetes.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["CG1192 Large for Gestational Age"],
      "consolidatedFrom": "Single guideline recommendation but clinically important for comprehensive care"
    },
    {
      "id": "4",
      "originalText": "Vague discussion of macrosomia risks",
      "suggestedText": "Document specific risk statistics (e.g., '5% shoulder dystocia risk at 4-4.25kg, 9% at 4.25-4.5kg')",
      "context": "CG1192 emphasizes 'discussing specific risks at different weight thresholds' (Section 9.0). FIGO guidelines stress 'integrating clinical judgment with objective data'. Providing quantifiable risks improves shared decision-making for this macrosomic fetus.",
      "category": "modification",
      "priority": "medium",
      "sourceGuidelines": ["CG1192 Large for Gestational Age", "FIGO Consensus Guidelines on Intrapartum Fetal Monitoring"],
      "consolidatedFrom": "Combines two guidelines recommending quantitative risk discussion"
    },
    {
      "id": "5",
      "originalText": "No documentation of STV value",
      "suggestedText": "Document exact STV value from CTG",
      "context": "MP037 guideline states 'STV <3ms is abnormal and strongly linked to metabolic acidaemia' (Section 'Short Term Variation'). Precise documentation is critical for interpreting borderline CTG findings in this high-risk pregnancy.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["MP037 Fetal Heart Monitoring guideline 2023"],
      "consolidatedFrom": "Single guideline recommendation but important for CTG interpretation"
    },
    {
      "id": "6",
      "originalText": "No documentation of contractions",
      "suggestedText": "Document contraction frequency/duration despite being 'not palpable'",
      "context": "FIGO guidelines require 'contraction assessment for CTG interpretation' (Section 4). Even non-palpable tightenings should be quantified as they may affect CTG interpretation in this borderline case.",
      "category": "addition",
      "priority": "low",
      "sourceGuidelines": ["FIGO Consensus Guidelines on Intrapartum Fetal Monitoring"],
      "consolidatedFrom": "Single guideline recommendation for completeness of documentation"
    }
  ],
  "guidelinesSummary": [
    {
      "guidelineTitle": "CG1192 Large for Gestational Age",
      "keyRecommendations": "1) Offer GTT for macrosomia 2) Discuss specific shoulder dystocia risks by weight 3) Consider CS for EFW ≥4.5kg",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "FIGO Consensus Guidelines on Intrapartum Fetal Monitoring",
      "keyRecommendations": "1) Continuous CTG for high-risk cases 2) Integrate clinical risks with CTG findings 3) Document contraction details",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "MP037 Fetal Heart Monitoring guideline 2023",
      "keyRecommendations": "1) Document exact STV values 2) Urgent review for non-reassuring CTG 3) Continuous monitoring for macrosomia",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "CG13019 Triage of Maternity Patients Guideline",
      "keyRecommendations": "1) Higher vigilance for DFM in high-risk cases 2) Document macrosomia counseling",
      "relevanceScore": "medium"
    },
    {
      "guidelineTitle": "CG1116 Fetal Heart Monitoring & Sampling",
      "keyRecommendations": "General recommendations only (guideline content unavailable)",
      "relevanceScore": "low"
    }
  ]
}

--- Token Usage Report ---
Prompt tokens: 4440
Completion tokens: 1430
Total tokens: 5870
Estimated cost: $0.002935